185 related articles for article (PubMed ID: 17453602)
21. Attention deficit/hyperactivity disorder across the lifespan.
Wilens TE; Biederman J; Spencer TJ
Annu Rev Med; 2002; 53():113-31. PubMed ID: 11818466
[TBL] [Abstract][Full Text] [Related]
22. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.
McCabe SE; Dickinson K; West BT; Wilens TE
J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066
[TBL] [Abstract][Full Text] [Related]
23. Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood?
Volkow ND; Swanson JM
Am J Psychiatry; 2008 May; 165(5):553-5. PubMed ID: 18450933
[No Abstract] [Full Text] [Related]
24. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents.
Riggs PD; Hall SK; Mikulich-Gilbertson SK; Lohman M; Kayser A
J Am Acad Child Adolesc Psychiatry; 2004 Apr; 43(4):420-9. PubMed ID: 15187802
[TBL] [Abstract][Full Text] [Related]
25. Attention deficit hyperactivity disorder (ADHD) and substance use disorders.
Wilson JJ; Levin FR
Curr Psychiatry Rep; 2001 Dec; 3(6):497-506. PubMed ID: 11707164
[TBL] [Abstract][Full Text] [Related]
26. When ADHD and substance use disorders intersect: relationship and treatment implications.
Wilens TE; Fusillo S
Curr Psychiatry Rep; 2007 Oct; 9(5):408-14. PubMed ID: 17915081
[TBL] [Abstract][Full Text] [Related]
27. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.
Wilens TE; Faraone SV; Biederman J; Gunawardene S
Pediatrics; 2003 Jan; 111(1):179-85. PubMed ID: 12509574
[TBL] [Abstract][Full Text] [Related]
28. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
29. Is OPTAx useful for monitoring the effect of stimulants on hyperactivity and inattention? A brief report.
Tabori-Kraft J; Sørensen MJ; Kaergaard M; Dalsgaard S; Thomsen PH
Eur Child Adolesc Psychiatry; 2007 Aug; 16(5):347-51. PubMed ID: 17476552
[TBL] [Abstract][Full Text] [Related]
30. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.
Kollins SH
J Atten Disord; 2008 Sep; 12(2):115-25. PubMed ID: 18192623
[TBL] [Abstract][Full Text] [Related]
31. Childhood stimulant treatment and risk for later substance abuse.
Fischer M; Barkley RA
J Clin Psychiatry; 2003; 64 Suppl 11():19-23. PubMed ID: 14529326
[TBL] [Abstract][Full Text] [Related]
32. Distinguishing comorbidity and successful management of adult ADHD.
Kooij JJ; Huss M; Asherson P; Akehurst R; Beusterien K; French A; Sasané R; Hodgkins P
J Atten Disord; 2012 Jul; 16(5 Suppl):3S-19S. PubMed ID: 22498754
[TBL] [Abstract][Full Text] [Related]
33. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study.
Barkley RA; Fischer M; Smallish L; Fletcher K
Pediatrics; 2003 Jan; 111(1):97-109. PubMed ID: 12509561
[TBL] [Abstract][Full Text] [Related]
34. Attention deficit hyperactivity disorder and substance use disorders.
Szobot CM; Bukstein O
Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
[TBL] [Abstract][Full Text] [Related]
35. The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood.
Harty SC; Ivanov I; Newcorn JH; Halperin JM
J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):331-9. PubMed ID: 21823914
[TBL] [Abstract][Full Text] [Related]
36. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.
Faraone SV; Biederman J; Wilens TE; Adamson J
Psychol Med; 2007 Dec; 37(12):1743-52. PubMed ID: 17349106
[TBL] [Abstract][Full Text] [Related]
37. Adult ADHD and substance abuse: diagnostic and treatment issues.
Kalbag AS; Levin FR
Subst Use Misuse; 2005; 40(13-14):1955-81, 2043-8. PubMed ID: 16282088
[TBL] [Abstract][Full Text] [Related]
38. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study.
Katusic SK; Barbaresi WJ; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):764-76. PubMed ID: 16262593
[TBL] [Abstract][Full Text] [Related]
39. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.
Wilens TE
J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375
[TBL] [Abstract][Full Text] [Related]
40. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
